SER Stock Analysis: Buy, Sell, or Hold?
SER - Serina Therapeutics, Inc.
$1.84
-0.08 (-4.17%)
▼
5d:
-9.8%
30d:
-7.07%
90d:
-24.28%
HOLD
LOW Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When SER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SER shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SER shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SER is currently trading at $1.84, which is considered fair relative to its 30-day fair value range of $1.72 to $1.97.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $1.99. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: SER has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+472.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SER is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $1.99. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: SER has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $11.00 (+472.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.72 -
$1.97
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.2%)
- BULLISH: Trading 472.9% below Wall St target ($11.00)
- CAUTION: Recommendation downgraded due to -9.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.72 -
$1.97
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.70
Resistance Level
$1.99
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.83
Wall Street Target
$11.00
(+472.9%)
Revenue Growth (YoY)
154.9%
Earnings Growth (YoY)
-43.5%
Share & Embed Analysis
Last updated: June 24, 2026 4:04 PM ET
Data refreshes hourly during market hours. Next update: 5:04 PM
Data refreshes hourly during market hours. Next update: 5:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SER showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 58 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 58 HOLD |
